Skip to content

Mirum Pharmaceuticals, Inc.

MIRM· NasdaqCore metricsCIK 1759425

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.41%
Market cap
$6.09B
65.28M shares
Filings
679
$185.72M
Q3 2026+54.7% FY25 yoy
-$40.77M
Q3 2026N/M FY25 yoy
-$59.75M
Q3 2026N/M FY25 yoy
-$279.32M
Q3 2026derived+488.0% FY25 yoy
-$0.87
Q3 2026N/M FY25 yoy
$243.19M
Q3 2026+33.3% FY25 yoy
$6.09B
—
9.1×
—
-4.50%
—

Twelve months to Sep 30, 2026 · derived

Price

$93.31+30.83%+$21.99past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$521.31MFY 2025
$521.31M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$521,312,000reported
FY 20242024-12-31$336,888,000reported
FY 20232023-12-31$186,374,000reported
FY 20222022-12-31$77,062,000reported
FY 20212021-12-31$19,138,000reported
FY 20202020-12-31$0reported

Segments

Products
Revenue by Products, FY2021 to FY2025FY2021Livmarli · FY2021 · $3.14MLicense · FY2021 · $16.00MLicense revenue · FY2021 · $16.00MFY2022Livmarli · FY2022 · $75.06MLicense and other revenue · FY2022 · $2.00MLicense · FY2022 · $2.00MLicense revenue · FY2022 · $2.00MFY2023Livmarli · FY2023 · $141.80MBile Acid Medicines · FY2023 · $37.08MLicense and other revenue · FY2023 · $7.50MLicense · FY2023 · $7.50MLicense revenue · FY2023 · $7.50MFY2024Livmarli · FY2024 · $213.30MBile Acid Medicines · FY2024 · $123.11MLicense and other revenue · FY2024 · $479.00KFY2025Livmarli · FY2025 · $360.01MBile Acid Medicines · FY2025 · $161.31M
LineFY2025ShareChange
Livmarli$360.01M69%+68.8%
Bile Acid Medicines$161.31M31%+31.0%
License and other revenue$0.00—−100.0%
License———
License revenue———
Total$521.31M

From the 10-K filed Feb 25, 2026MIRM

Pharmaceutical preparations

Mirum Pharmaceuticals, Inc. is the 54th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Mirum Pharmaceuticals, Inc. · CIK 1759425 · Engraved from SEC EDGAR